• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PD-L1 表达增加限制非酒精性脂肪性肝病中的肝损伤。

Increased PD-L1 Restricts Liver Injury in Nonalcoholic Fatty Liver Disease.

机构信息

Department of Gastroenterology and Hepatology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.

Liver Cancer Institute, Zhongshan Hospital, Fudan University and Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, China.

出版信息

Oxid Med Cell Longev. 2022 May 16;2022:5954437. doi: 10.1155/2022/5954437. eCollection 2022.

DOI:10.1155/2022/5954437
PMID:35615575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9126662/
Abstract

PD-L1 is a critical checkpoint that protects tissues from autoimmune injury. Nevertheless, the role of PD-L1 in nonalcoholic fatty liver disease- (NAFLD-) induced liver damage is still unclear. In this study, we examined the role and mechanism of PD-L1 expression on NAFLD-induced liver damage and PD-L1 expression in the livers from patients with NAFLD, and LO2 cells treated by FFA, was significantly increased. FFA triggers a large amount of ROS (generated from NOX4 and damaged mitochondria), promoting the ZNF24 expression and suppressing ZN24 sumoylation, both of which enhance the PD-L1 transcription and expression. The knockdown of PD-L1 increases CD8 + T cells' damage to FFA-treated LO2 cells, while its upregulation limits the liver injury in NAFLD models. Collectively, we demonstrate that FFA promotes PD-L1 expression through the ROS/ZNF24 pathway and suppresses UBE2I-mediated ZNF24 sumoylation to enhance its transcriptional activity of PD-L1. PD-L1 upregulation limits FFA-induced injury of hepatocytes and .

摘要

PD-L1 是一个关键的检查点,可保护组织免受自身免疫损伤。然而,PD-L1 在非酒精性脂肪性肝病(NAFLD)引起的肝损伤中的作用尚不清楚。在这项研究中,我们研究了 PD-L1 在 NAFLD 诱导的肝损伤中的作用和机制,以及 PD-L1 在 NAFLD 患者肝脏中的表达。结果发现,游离脂肪酸(FFA)显著增加 LO2 细胞中 PD-L1 的表达。FFA 触发大量 ROS(由 NOX4 和受损线粒体产生),促进 ZNF24 的表达并抑制 ZN24 的 sumoylation,这两者均增强了 PD-L1 的转录和表达。PD-L1 的敲低增加了 CD8+T 细胞对 FFA 处理的 LO2 细胞的损伤,而上调 PD-L1 则限制了 NAFLD 模型中的肝损伤。总之,我们证明了 FFA 通过 ROS/ZNF24 途径促进 PD-L1 的表达,并抑制 UBE2I 介导的 ZNF24 sumoylation,从而增强其 PD-L1 的转录活性。PD-L1 的上调限制了 FFA 诱导的肝细胞损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/e45a7bae69be/OMCL2022-5954437.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/1a1b94272e50/OMCL2022-5954437.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/cf400d3d0cb1/OMCL2022-5954437.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/603364d81e20/OMCL2022-5954437.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/4ff21d28ede8/OMCL2022-5954437.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/1af5ca660a39/OMCL2022-5954437.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/742257ef2ba8/OMCL2022-5954437.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/e3c9de1f93ae/OMCL2022-5954437.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/e45a7bae69be/OMCL2022-5954437.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/1a1b94272e50/OMCL2022-5954437.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/cf400d3d0cb1/OMCL2022-5954437.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/603364d81e20/OMCL2022-5954437.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/4ff21d28ede8/OMCL2022-5954437.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/1af5ca660a39/OMCL2022-5954437.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/742257ef2ba8/OMCL2022-5954437.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/e3c9de1f93ae/OMCL2022-5954437.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7f7/9126662/e45a7bae69be/OMCL2022-5954437.008.jpg

相似文献

1
Increased PD-L1 Restricts Liver Injury in Nonalcoholic Fatty Liver Disease.PD-L1 表达增加限制非酒精性脂肪性肝病中的肝损伤。
Oxid Med Cell Longev. 2022 May 16;2022:5954437. doi: 10.1155/2022/5954437. eCollection 2022.
2
Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic Injury Modulating PKC-β/p66Shc/ROS and Endoplasmic Reticulum Stress Pathways.异甜菊醇通过调节蛋白激酶 C-β/p66Shc/活性氧和内质网应激途径保护游离脂肪酸和高脂饮食诱导的肝损伤。
Antioxid Redox Signal. 2019 Jun 10;30(17):1949-1968. doi: 10.1089/ars.2018.7521. Epub 2019 Jan 28.
3
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.通过靶向脂肪酸转运蛋白 2 调节髓源性抑制细胞中的 ROS 增强抗 PD-L1 肿瘤免疫治疗。
Cell Immunol. 2021 Apr;362:104286. doi: 10.1016/j.cellimm.2021.104286. Epub 2021 Jan 19.
4
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.miR-122 通过靶向 Sirt1 抑制 LKB1/AMPK 通路促进非酒精性脂肪性肝病中的肝脂肪生成。
Mol Med. 2019 Jun 13;25(1):26. doi: 10.1186/s10020-019-0085-2.
5
Water Extract of Dolichos lablab Attenuates Hepatic Lipid Accumulation in a Cellular Nonalcoholic Fatty Liver Disease Model.白扁豆水提取物减轻细胞非酒精性脂肪性肝病模型中的肝脏脂质积累
J Med Food. 2016 May;19(5):495-503. doi: 10.1089/jmf.2015.3623.
6
Hesperetin ameliorates hepatic oxidative stress and inflammation the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD.橙皮苷通过 PI3K/AKT-Nrf2-ARE 通路改善油酸诱导的 HepG2 细胞和高脂饮食诱导的 NAFLD 大鼠模型的肝氧化应激和炎症。
Food Funct. 2021 May 11;12(9):3898-3918. doi: 10.1039/d0fo02736g.
7
Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.持续表达 PD-L1 的 CTL 耐受为小鼠脓毒症提供了一种新的治疗方法。
Theranostics. 2019 Mar 16;9(7):2003-2016. doi: 10.7150/thno.28057. eCollection 2019.
8
Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.芪味铁屑胶囊通过调控 LXRα、PPARγ、NF-κB-iNOS-NO 信号通路对 3T3-L1 脂肪细胞及非酒精性脂肪性肝病大鼠的保护作用及机制研究。
J Ethnopharmacol. 2019 May 23;236:316-325. doi: 10.1016/j.jep.2019.03.006. Epub 2019 Mar 6.
9
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease.葡萄糖激酶将 Krüppel 样因子 6 与非酒精性脂肪性肝病中肝脏胰岛素敏感性的调节联系起来。
Hepatology. 2012 Apr;55(4):1083-93. doi: 10.1002/hep.24793. Epub 2012 Mar 1.
10
Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.乙型肝炎病毒触发的 PTEN/β-catenin/c-Myc 信号通路增强 PD-L1 的表达以促进免疫逃逸。
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G162-G173. doi: 10.1152/ajpgi.00197.2019. Epub 2019 Oct 11.

引用本文的文献

1
Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease.解读免疫T细胞的作用:改善代谢相关脂肪性肝病的新领域。
Imeta. 2023 Jan 18;2(1):e76. doi: 10.1002/imt2.76. eCollection 2023 Feb.
2
Association of urinary chlorpyrifos, paraquat, and cyproconazole levels with the severity of fatty liver based on MRI.基于 MRI 的尿中氯菊酯、百草枯和环丙唑醇水平与脂肪肝严重程度的关联。
BMC Public Health. 2024 Mar 14;24(1):807. doi: 10.1186/s12889-024-18129-1.
3
Injury activated alveolar progenitors (IAAPs): the underdog of lung repair.

本文引用的文献

1
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology.非酒精性脂肪性肝病的遗传途径:系统生物学的见解。
Hepatology. 2020 Jul;72(1):330-346. doi: 10.1002/hep.31229.
2
Simvastatin Mitigates Apoptosis and Transforming Growth Factor-Beta Upregulation in Stretch-Induced Endothelial Cells.辛伐他汀减轻拉伸诱导的内皮细胞凋亡和转化生长因子-β上调。
Oxid Med Cell Longev. 2019 Dec 17;2019:6026051. doi: 10.1155/2019/6026051. eCollection 2019.
3
CD8 T cells regulate liver injury in obesity-related nonalcoholic fatty liver disease.
损伤激活的肺泡祖细胞(IAAPs):肺部修复的潜力股。
Cell Mol Life Sci. 2023 May 11;80(6):145. doi: 10.1007/s00018-023-04789-6.
4
Methyl Ferulic Acid Alleviates Neuropathic Pain by Inhibiting Nox4-induced Ferroptosis in Dorsal Root Ganglia Neurons in Rats.甲基阿魏酸通过抑制背根神经节神经元中 Nox4 诱导的铁死亡缓解大鼠的神经性疼痛。
Mol Neurobiol. 2023 Jun;60(6):3175-3189. doi: 10.1007/s12035-023-03270-6. Epub 2023 Feb 22.
5
Crucial role of T cells in NAFLD-related disease: A review and prospect.T 细胞在非酒精性脂肪性肝病相关疾病中的关键作用:综述与展望。
Front Endocrinol (Lausanne). 2022 Nov 15;13:1051076. doi: 10.3389/fendo.2022.1051076. eCollection 2022.
CD8 T 细胞调节肥胖相关非酒精性脂肪性肝病中的肝损伤。
Am J Physiol Gastrointest Liver Physiol. 2020 Feb 1;318(2):G211-G224. doi: 10.1152/ajpgi.00040.2019. Epub 2019 Nov 11.
4
Analysis of the PD-1/PD-L1 axis in human autoimmune thyroid disease: Insights into pathogenesis and clues to immunotherapy associated thyroid autoimmunity.分析 PD-1/PD-L1 轴在人类自身免疫性甲状腺疾病中的作用:对发病机制的深入了解和免疫治疗相关甲状腺自身免疫的线索。
J Autoimmun. 2019 Sep;103:102285. doi: 10.1016/j.jaut.2019.05.013. Epub 2019 Jun 8.
5
Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.持续表达 PD-L1 的 CTL 耐受为小鼠脓毒症提供了一种新的治疗方法。
Theranostics. 2019 Mar 16;9(7):2003-2016. doi: 10.7150/thno.28057. eCollection 2019.
6
Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1.活性氧物种通过上调 PD-L1 调节巨噬细胞的免疫抑制表型。
Proc Natl Acad Sci U S A. 2019 Mar 5;116(10):4326-4335. doi: 10.1073/pnas.1819473116. Epub 2019 Feb 15.
7
Molecular pathways of nonalcoholic fatty liver disease development and progression.非酒精性脂肪性肝病发生和进展的分子途径。
Cell Mol Life Sci. 2019 Jan;76(1):99-128. doi: 10.1007/s00018-018-2947-0. Epub 2018 Oct 20.
8
Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.原花青素 B2 通过调节 TFEB 介导线粒体途径和氧化还原状态改善游离脂肪酸诱导的肝脂肪变性。
Free Radic Biol Med. 2018 Oct;126:269-286. doi: 10.1016/j.freeradbiomed.2018.08.024. Epub 2018 Aug 22.
9
Mechanisms of NAFLD development and therapeutic strategies.非酒精性脂肪性肝病发病机制及治疗策略。
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
10
Regulation and Function of the PD-L1 Checkpoint.PD-L1 检查点的调控与功能
Immunity. 2018 Mar 20;48(3):434-452. doi: 10.1016/j.immuni.2018.03.014.